Galectin-1 and galectin-3 constitute novel-binding partners for Factor VIII

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 5, 2016, Pages 855-863

  O'Sullivan, Jamie M ^a   Jenkins, P Vince ^a   Rawley, Orla ^a   Gegenbauer, Kristina ^a   Chion, Alain ^a   Lavin, Michelle ^a   Byrne, Barry ^d   O'Kennedy, Richard ^d   Preston, Roger J S ^c,e   Brophy, Teresa M ^a   O'Donnell, James S ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d DUBLIN CITY UNIVERSITY   (Ireland)

^e OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

factor VIII; galectins; glycosylation; lectins; plasma

Indexed keywords

BLOOD CLOTTING FACTOR 8; GALECTIN 1; GALECTIN 3; GLYCAN; GLYCOSIDASE; RECOMBINANT BLOOD CLOTTING FACTOR 8; F8 PROTEIN, HUMAN; GALECTIN-3, HUMAN; LGALS1 PROTEIN, HUMAN; PROTEIN BINDING; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BHK CELL LINE; BINDING AFFINITY; BLOOD CLOTTING; CHO CELL LINE; CONTROLLED STUDY; FEMALE; IMMUNOADSORPTION; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SURFACE PLASMON RESONANCE; ANIMAL; BINDING SITE; CHEMISTRY; COMPARATIVE STUDY; CRICETULUS; GENETIC TRANSFECTION; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM; PARTIAL THROMBOPLASTIN TIME; PROTEIN CONFORMATION;

ANIMALS; BINDING SITES; BLOOD COAGULATION; CHO CELLS; CRICETULUS; FACTOR VIII; GALECTIN 1; GALECTIN 3; GLYCOSYLATION; HUMANS; PARTIAL THROMBOPLASTIN TIME; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 84961618438     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306915     Document Type: Article

References (53)

1. van Dieijen G, Tans G, Rosing J, Hemker HC, The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981 256 3433 3442
2. Terraube V, O'Donnell JS, Jenkins PV, Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance. Haemophilia 2010 16 3 13. doi: 10.1111/j.1365-2516.2009.02005.x
3. Everett LA, Cleuren AC, Khoriaty RN, Ginsburg D, Murine coagulation factor VIII is synthesized in endothelial cells. Blood 2014 123 3697 3705. doi: 10.1182/blood-2014-02-554501
4. Fahs SA, Hille MT, Shi Q, Weiler H, Montgomery RR, A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII. Blood 2014 123 3706 3713. doi: 10.1182/blood-2014-02-555151
5. Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenham EG, Lawn RM, Capon DJ, Structure of human factor VIII. Nature 1984 312 337 342
6. Wood WI, Capon DJ, Simonsen CC, Eaton DL, Gitschier J, Keyt B, Seeburg PH, Smith DH, Hollingshead P, Wion KL, Delwart E, Tuddenham EG, Vehar GA, Lawn RM, Expression of active human factor VIII from recombinant DNA clones. Nature 1984 312 330 337
7. Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Buecker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC, Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984 312 342 347
8. Pipe SW, Functional roles of the factor VIII B domain. Haemophilia 2009 15 1187 1196. doi: 10.1111/j.1365-2516.2009.02026.x
9. Ganz PR, Atkins JS, Palmer DS, Dudani AK, Hashemi S, Luison F, Definition of the affinity of binding between human von Willebrand factor and coagulation factor VIII. Biochem Biophys Res Commun 1991 180 231 237
10. Vlot AJ, Koppelman SJ, van den Berg MH, Bouma BN, Sixma JJ, The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood 1995 85 3150 3157
11. Kaufman RJ, Wasley LC, Dorner AJ, Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 1988 263 6352 6362
12. Mazsaroff I, Yu W, Kelley BD, Vath JE, Quantitative comparison of global carbohydrate structures of glycoproteins using LC-MS and in-source fragmentation. Anal Chem 1997 69 2517 2524
13. Hironaka T, Furukawa K, Esmon PC, Fournel MA, Sawada S, Kato M, Minaga T, Kobata A, Comparative study of the sugar chains of factor VIII purified from human plasma and from the culture media of recombinant baby hamster kidney cells. J Biol Chem 1992 267 8012 8020
14. Medzihradszky KF, Besman MJ, Burlingame AL, Structural characterization of site-specific N-glycosylation of recombinant human factor VIII by reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry. Anal Chem 1997 69 3986 3994
15. Schilow WF, Schoerner-Burkhardt E, Seitz R, Charge analysis of N-glycans from human recombinant coagulation factor VIII and human FVIII standards. Thromb Haemost 2004 92 427 428. doi: 10.1267/THRO04020427
16. Jenkins PV, O'Donnell JS, ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 2006 46 1836 1844. doi: 10.1111/j.1537-2995.2006.00975.x
17. Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A, A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood 2008 111 3540 3545. doi: 10.1182/blood-2007-11-122945
18. Pipe SW, Morris JA, Shah J, Kaufman RJ, Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin. J Biol Chem 1998 273 8537 8544
19. Moussalli M, Pipe SW, Hauri HP, Nichols WC, Ginsburg D, Kaufman RJ, Mannose-dependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53-mediated ER to Golgi trafficking of coagulation factors V and VIII. J Biol Chem 1999 274 32539 32542
20. Zhang B, Kaufman RJ, Ginsburg D, LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J Biol Chem 2005 280 25881 25886. doi: 10.1074/jbc.M502160200
21. Dasgupta S, Navarrete AM, Bayry J, A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes. Proc Natl Acad Sci U S A 2007 104 8965 8970. doi: 10.1073/pnas.0702120104
22. Preston RJ, Rawley O, Gleeson EM, O'Donnell JS, Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities. Blood 2013 121 3801 3810. doi: 10.1182/blood-2012-10-415000
23. Bovenschen N, Rijken DC, Havekes LM, van Vlijmen BJ, Mertens K, The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor. J Thromb Haemost 2005 3 1257 1265. doi: 10.1111/j.1538-7836.2005.01389.x
24. Barondes SH, Cooper DN, Gitt MA, Leffler H, Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994 269 20807 20810
25. Cooper DN, Galectinomics: finding themes in complexity. Biochim Biophys Acta 2002 1572 209 231
26. Thijssen VL, Hulsmans S, Griffioen AW, The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am J Pathol 2008 172 545 553. doi: 10.2353/ajpath.2008.070938
27. DeRoo EP, Wrobleski SK, Shea EM, Al-Khalil RK, Hawley AE, Henke PK, Myers DD Jr, Wakefield TW, Diaz JA, The role of galectin-3 and galectin-3-binding protein in venous thrombosis. Blood 2015 125 1813 1821. doi: 10.1182/blood-2014-04-569939
28. Saint-Lu N, Oortwijn BD, Pegon JN, Odouard S, Christophe OD, de Groot PG, Denis CV, Lenting PJ, Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor. Arterioscler Thromb Vasc Biol 2012 32 894 901. doi: 10.1161/ATVBAHA.111.240309
29. Lenting PJ, Pegon JN, Christophe OD, Denis CV, Factor VIII and von Willebrand factor-Too sweet for their own good. Haemophilia 2010 16 suppl 5 194 199. doi: 10.1111/j.1365-2516.2010.02320.x
30. McGrath RT, McKinnon TA, Byrne B, O'Kennedy R, Terraube V, McRae E, Preston RJ, Laffan MA, O'Donnell JS, Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13. Blood 2010 115 2666 2673. doi: 10.1182/blood-2009-09-241547
31. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE, Yagi F, Kasai K, Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 2002 1572 232 254
32. Demetriou M, Granovsky M, Quaggin S, Dennis JW, Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001 409 733 739. doi: 10.1038/35055582
33. Lenting PJ, van Mourik JA, Mertens K, The life cycle of coagulation factor VIII in view of its structure and function. Blood 1998 92 3983 3996
34. Dias-Baruffi M, Stowell SR, Song SC, Arthur CM, Cho M, Rodrigues LC, Montes MA, Rossi MA, James JA, McEver RP, Cummings RD, Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle. Glycobiology 2010 20 507 520. doi: 10.1093/glycob/cwp203
35. Markowska AI, Jefferies KC, Panjwani N, Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. J Biol Chem 2011 286 29913 29921. doi: 10.1074/jbc.M111.226423
36. Camby I, Le Mercier M, Lefranc F, Kiss R, Galectin-1: a small protein with major functions. Glycobiology 2006 16 137R 157R. doi: 10.1093/glycob/cwl025
37. Varki A, Natural ligands for CD33-related Siglecs? Glycobiology 2009 19 810 812. doi: 10.1093/glycob/cwp063
38. Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, Leffler H, Smith DF, Cummings RD, Galectin-1,-2, and-3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 2008 283 10109 10123. doi: 10.1074/jbc.M709545200
39. Rabinovich GA, Ariel A, Hershkoviz R, Hirabayashi J, Kasai KI, Lider O, Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1. Immunology 1999 97 100 106
40. Rabinovich GA, Rubinstein N, Toscano MA, Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta 2002 1572 274 284
41. Gouw SC, van der Bom JG, Ljung R, PedNet and RODIN Study Group Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med 2013 368 231 239. doi: 10.1056/NEJMoa1208024
42. Collins PW, Palmer BP, Chalmers EA, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR, UK Haemophilia Centre Doctors' Organization Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011. Blood 2014 124 3389 3397. doi: 10.1182/blood-2014-07-580498
43. Cederfur C, Salomonsson E, Nilsson J, Halim A, Oberg CT, Larson G, Nilsson UJ, Leffler H, Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins. Glycobiology 2008 18 384 394. doi: 10.1093/glycob/cwn015
44. Tuddenham EG, Lane RS, Rotblat F, Johnson AJ, Snape TJ, Middleton S, Kernoff PB, Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br J Haematol 1982 52 259 267
45. van Schooten CJ, Shahbazi S, Groot E, Oortwijn BD, van den Berg HM, Denis CV, Lenting PJ, Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo. Blood 2008 112 1704 1712. doi: 10.1182/blood-2008-01-133181
46. Castro-Núñez L, Dienava-Verdoold I, Herczenik E, Mertens K, Meijer AB, Shear stress is required for the endocytic uptake of the factor VIII-von Willebrand factor complex by macrophages. J Thromb Haemost 2012 10 1929 1937. doi: 10.1111/j.1538-7836.2012.04860.x
47. Rastegarlari G, Pegon JN, Casari C, Odouard S, Navarrete AM, Saint-Lu N, van Vlijmen BJ, Legendre P, Christophe OD, Denis CV, Lenting PJ, Macrophage LRP1 contributes to the clearance of von Willebrand factor. Blood 2012 119 2126 2134. doi: 10.1182/blood-2011-08-373605
48. Pacienza N, Pozner RG, Bianco GA, D'Atri LP, Croci DO, Negrotto S, Malaver E, Gómez RM, Rabinovich GA, Schattner M, The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB J 2008 22 1113 1123. doi: 10.1096/fj.07-9524com
49. Romaniuk MA, Croci DO, Lapponi MJ, Tribulatti MV, Negrotto S, Poirier F, Campetella O, Rabinovich GA, Schattner M, Binding of galectin-1 to αIIβ3 integrin triggers "outside-in" signals, stimulates platelet activation, and controls primary hemostasis. FASEB J 2012 26 2788 2798. doi: 10.1096/fj.11-197541
50. Dumic J, Dabelic S, Flögel M, Galectin-3: an open-ended story. Biochim Biophys Acta 2006 1760 616 635. doi: 10.1016/j.bbagen.2005.12.020
51. Barrow H, Guo X, Wandall HH, Pedersen JW, Fu B, Zhao Q, Chen C, Rhodes JM, Yu LG, Serum galectin-2,-4, and-8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clin Cancer Res 2011 17 7035 7046. doi: 10.1158/1078-0432.CCR-11-1462
52. Diaz JA, Ramacciotti E, Wakefield TW, Do galectins play a role in venous thrombosis? a review. Thromb Res 2010 125 373 376. doi: 10.1016/j.thromres.2009.11.011
53. Ramacciotti E, Hawley AE, Wrobleski SK, Myers DD Jr, Strahler JR, Andrews PC, Guire KE, Henke PK, Wakefield TW, Proteomics of microparticles after deep venous thrombosis. Thromb Res 2010 125 e269 e274. doi: 10.1016/j.thromres.2010.01.019